211 related articles for article (PubMed ID: 31881859)
21. Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy.
Scott Sutton S; Magagnoli J; Hardin JW
Pharmacotherapy; 2016 Apr; 36(4):385-401. PubMed ID: 26923931
[TBL] [Abstract][Full Text] [Related]
22. Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy.
Melku M; Abebe G; Teketel A; Asrie F; Yalew A; Biadgo B; Kassa E; Damtie D; Anlay DZ
Environ Health Prev Med; 2020 Aug; 25(1):43. PubMed ID: 32838734
[TBL] [Abstract][Full Text] [Related]
23. Barriers to viral load suppression among adolescents living with HIV on anti-retroviral therapy: a retrospective study in Tanga, Tanzania.
Mushy SE; Mtisi E; Mkawe S; Mboggo E; Ndega J; Yahya-Malima KI; Kamugunya D; Kilimba ES; Mlay BS; Muya A; Ngalesoni F
AIDS Res Ther; 2024 May; 21(1):35. PubMed ID: 38778318
[TBL] [Abstract][Full Text] [Related]
24. Low Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort Study.
Mulu A; Maier M; Liebert UG
PLoS One; 2015; 10(10):e0141318. PubMed ID: 26512902
[TBL] [Abstract][Full Text] [Related]
25. Treatment outcomes and their determinants in HIV patients on Anti-retroviral Treatment Program in selected health facilities of Kembata and Hadiya zones, Southern Nations, Nationalities and Peoples Region, Ethiopia.
Ayele W; Mulugeta A; Desta A; Rabito FA
BMC Public Health; 2015 Aug; 15():826. PubMed ID: 26310943
[TBL] [Abstract][Full Text] [Related]
26. Antiretroviral treatment failure and associated factors among HIV patients on first-line antiretroviral treatment in Sekota, northeast Ethiopia.
Nega J; Taye S; Million Y; Rodrigo C; Eshetie S
AIDS Res Ther; 2020 Jul; 17(1):39. PubMed ID: 32650796
[TBL] [Abstract][Full Text] [Related]
27. Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study.
O'Connor J; Smith C; Lampe FC; Johnson MA; Chadwick DR; Nelson M; Dunn D; Winston A; Post FA; Sabin C; Phillips AN;
Lancet HIV; 2017 Jul; 4(7):e295-e302. PubMed ID: 28479492
[TBL] [Abstract][Full Text] [Related]
28. The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data.
Dolling DI; Goodall RL; Chirara M; Hakim J; Nkurunziza P; Munderi P; Eram D; Tumukunde D; Spyer MJ; Gilks CF; Kaleebu P; Dunn DT; Pillay D;
BMC Infect Dis; 2017 Feb; 17(1):160. PubMed ID: 28222702
[TBL] [Abstract][Full Text] [Related]
29. Immune recovery after antiretroviral therapy initiation: a challenge for people living with HIV in Brazil.
Mendicino CCP; Moodie EEM; Guimarães MDC; Pádua CAM
Cad Saude Publica; 2021; 37(9):e00143520. PubMed ID: 34669770
[TBL] [Abstract][Full Text] [Related]
30. Antiretroviral therapy initiation within seven days of enrolment: outcomes and time to undetectable viral load among children at an urban HIV clinic in Uganda.
Ssebunya R; Wanyenze RK; Lukolyo H; Mutto M; Kisitu G; Amuge P; Maganda A; Kekitiinwa A
BMC Infect Dis; 2017 Jun; 17(1):439. PubMed ID: 28629459
[TBL] [Abstract][Full Text] [Related]
31. Incidence and predictors of anemia among adults on HIV care at South Gondar Zone Public General Hospital Northwest Ethiopia, 2020; retrospective cohort study.
Tigabu A; Beyene Y; Getaneh T; Chekole B; Gebremaryam T; Sisay Chanie E; Selomom N; Alene T; Aragie G; Legas G; Dessie G
PLoS One; 2022; 17(1):e0259944. PubMed ID: 35020736
[TBL] [Abstract][Full Text] [Related]
32. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
Prendergast A; Mphatswe W; Tudor-Williams G; Rakgotho M; Pillay V; Thobakgale C; McCarthy N; Morris L; Walker BD; Goulder P
AIDS; 2008 Jul; 22(11):1333-43. PubMed ID: 18580613
[TBL] [Abstract][Full Text] [Related]
33. Transmission dynamics among participants initiating antiretroviral therapy upon diagnosis of early acute HIV-1 infection in Thailand.
Kroon E; Pham PT; Sirivichayakul S; Trichavaroj R; Colby DJ; Pinyakorn S; Phanuphak N; Sanders-Buell E; van Griensven F; Kijak GH; Kim JH; Michael NL; Robb ML; Ananworanich J; De Souza MS; Tovanabutra S;
AIDS; 2018 Oct; 32(16):2373-2381. PubMed ID: 30096068
[TBL] [Abstract][Full Text] [Related]
34. The effect of a "universal antiretroviral therapy" recommendation on HIV RNA levels among HIV-infected patients entering care with a CD4 count greater than 500/μL in a public health setting.
Geng EH; Hare CB; Kahn JO; Jain V; Van Nunnery T; Christopoulos KA; Deeks SG; Gandhi M; Havlir DV
Clin Infect Dis; 2012 Dec; 55(12):1690-7. PubMed ID: 22955429
[TBL] [Abstract][Full Text] [Related]
35. Nearly one in every six HIV-infected children lost from ART follow-up at Debre Markos Referral Hospital, Northwest Ethiopia: A 14-year retrospective follow-up study.
Hibstie YT; Kibret GD; Talie A; Temesgen B; Melkamu MW; Alebel A
PLoS One; 2020; 15(9):e0239013. PubMed ID: 32931502
[TBL] [Abstract][Full Text] [Related]
36. Predictors of Treatment Failure among Adult Antiretroviral Treatment (ART) Clients in Bale Zone Hospitals, South Eastern Ethiopia.
Haile D; Takele A; Gashaw K; Demelash H; Nigatu D
PLoS One; 2016; 11(10):e0164299. PubMed ID: 27716827
[TBL] [Abstract][Full Text] [Related]
37. Predictors of mortality among children on Antiretroviral Therapy at a referral hospital, Northwest Ethiopia: a retrospective follow up study.
Koye DN; Ayele TA; Zeleke BM
BMC Pediatr; 2012 Oct; 12():161. PubMed ID: 23043325
[TBL] [Abstract][Full Text] [Related]
38. The effect of "universal test and treat" program on HIV treatment outcomes and patient survival among a cohort of adults taking antiretroviral treatment (ART) in low income settings of Gurage zone, South Ethiopia.
Girum T; Yasin F; Wasie A; Shumbej T; Bekele F; Zeleke B
AIDS Res Ther; 2020 May; 17(1):19. PubMed ID: 32423457
[TBL] [Abstract][Full Text] [Related]
39. Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.
Okomo U; Togun T; Oko F; Peterson K; Townend J; Peterson I; Jaye A
BMC Pediatr; 2012 Jul; 12():95. PubMed ID: 22770231
[TBL] [Abstract][Full Text] [Related]
40. Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients.
; Vandenhende MA; Ingle S; May M; Chene G; Zangerle R; Van Sighem A; Gill MJ; Schwarze-Zander C; Hernandez-Novoa B; Obel N; Kirk O; Abgrall S; Guest J; Samji H; D'Arminio Monforte A; Llibre JM; Smith C; Cavassini M; Burkholder GA; Shepherd B; Crane HM; Sterne J; Morlat P
AIDS; 2015 Jan; 29(3):373-83. PubMed ID: 25686685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
